INLIF LIMITED Ordinary Shares (INLF) - Total Liabilities
Based on the latest financial reports, INLIF LIMITED Ordinary Shares (INLF) has total liabilities worth $7.10 Million USD as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore INLIF LIMITED Ordinary Shares (INLF) cash flow conversion to assess how effectively this company generates cash.
INLIF LIMITED Ordinary Shares - Total Liabilities Trend (2021–2024)
This chart illustrates how INLIF LIMITED Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data. See INLF net asset value for net asset value and shareholders' equity analysis.
INLIF LIMITED Ordinary Shares Competitors by Total Liabilities
The table below lists competitors of INLIF LIMITED Ordinary Shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hancom WITH Inc
KQ:054920
|
Korea | ₩93.59 Billion |
|
Tasco Bhd
KLSE:5140
|
Malaysia | RM1.40 Billion |
|
Elevate Uranium Ltd
AU:EL8
|
Australia | AU$1.57 Million |
|
Apetit Oyj
HE:APETIT
|
Finland | €37.60 Million |
|
Nusa Raya Cipta Tbk
JK:NRCA
|
Indonesia | Rp1.41 Trillion |
|
Coya Therapeutics, Inc. Common Stock
NASDAQ:COYA
|
USA | $4.76 Million |
|
Hasen-Immobilien AG
STU:ABHA
|
Germany | €83.22 Million |
|
Banco Santander Río S.A
BA:BRIO
|
Argentina | AR$19.89 Trillion |
Liability Composition Analysis (2021–2024)
This chart breaks down INLIF LIMITED Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of INLIF LIMITED Ordinary Shares.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.43 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.45 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how INLIF LIMITED Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for INLIF LIMITED Ordinary Shares (2021–2024)
The table below shows the annual total liabilities of INLIF LIMITED Ordinary Shares from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $8.20 Million | +16.19% |
| 2023-12-31 | $7.06 Million | +123.03% |
| 2022-12-31 | $3.16 Million | -74.88% |
| 2021-12-31 | $12.60 Million | -- |
About INLIF LIMITED Ordinary Shares
INLIF Limited, through its subsidiaries, engages in the research, development, manufacture, and sale of injection molding machine-dedicated manipulator arms under the iNLIF brand in the People's Republic of China. The company offers transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms, as well a… Read more